Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2020-05-04 08:05:03]
5 Years H
4
Impact Factor
0.06
5 Years IF
0.05
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.1 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.11 0 0 0 0 0 0 0 0 0 0 0.06
1995 0 0.2 0 0 0 0 0 0 0 0 0 0 0.08
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.1
1997 0 0.23 0 0 0 0 0 0 0 0 0 0 0.1
1998 0 0.27 0 0 0 0 0 0 0 0 0 0 0.12
1999 0 0.29 0 0 0 0 0 0 0 0 0 0 0.14
2000 0 0.34 0 0 0 0 0 0 0 0 0 0 0.15
2001 0 0.37 0 0 0 0 0 0 0 0 0 0 0.16
2002 0 0.4 0 0 0 0 0 0 0 0 0 0 0.21
2003 0 0.41 0 0 0 0 0 0 0 0 0 0 0.2
2004 0 0.46 0 0 0 0 0 0 0 0 0 0 0.21
2005 0 0.47 0 0 0 0 0 0 0 0 0 0 0.22
2006 0 0.47 0 0 0 0 0 0 0 0 0 0 0.21
2007 0 0.43 0 0 0 0 0 0 0 0 0 0 0.19
2008 0 0.45 0 0 0 0 0 0 0 0 0 0 0.21
2009 0 0.45 0 0 0 0 0 0 0 0 0 0 0.22
2010 0 0.44 0 0 0 0 0 0 0 0 0 0 0.18
2011 0 0.47 0 0 0 0 0 0 0 0 0 0 0.21
2012 0 0.47 0 0 0 0 0 0 0 0 0 0 0.2
2013 0 0.54 0 0 0 0 0 0 0 0 0 0 0.22
2014 0 0.55 0 0 8 8 6 0 0 0 0 0 0.22
2015 0 0.56 0 0 0 8 0 0 8 8 0 0 0.22
2016 0.13 0.57 0.1 0.13 109 117 49 12 12 8 1 8 1 12 100 11 0.1 0.2
2017 0.15 0.59 0.14 0.16 119 236 32 33 45 109 16 117 19 30 90.9 9 0.08 0.21
2018 0.12 0.72 0.16 0.12 134 370 28 58 103 228 28 236 29 53 91.4 21 0.16 0.29
2019 0.06 0.92 0.12 0.05 113 483 7 57 160 253 14 370 20 56 98.2 21 0.19 0.35
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Antoni, ; Tregunno, Phil ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Callahan, Alison ; Low, Yen ; Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

5
32016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

5
42016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

4
52016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

4
62017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Caster, Ola ; Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

4
72018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Trifiro, Gianluca ; Bate, Andrew ; Sultana, Janet. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
82017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Iyer, Geetha ; Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
92017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark ; Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

2
102016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Wahab, Izyan A ; Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

2
1120192
122017Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan. (2017). Ozawa, Kazuki ; Ikeda, Shu-Ichi ; Ishihara, Sakiko ; Kinoshita, Tomomi ; Hineno, Akiyo. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0574-6.

Full description at Econpapers || Download paper

2
132016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Sarker, Abeed ; Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

2
142018Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths. (2018). Ferner, Robin E ; Cox, Anthony R ; Easton, Craig. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0588-0.

Full description at Econpapers || Download paper

2
152016Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G ; Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

2
1620192
172017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). Vries, Sieta T ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

2
182018Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs. (2018). Cheng, Ning ; Hansen, Richard A ; Page, David C ; Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:4:d:10.1007_s40264-017-0624-0.

Full description at Econpapers || Download paper

2
192016Drug Interactions of Direct-Acting Oral Anticoagulants. (2016). Fitzgerald, John Leonard ; Howes, Laurence Guy . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0443-8.

Full description at Econpapers || Download paper

2
202018Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Saucier, Roxanne ; Dasgupta, Nabarun ; Wolfe, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0685-8.

Full description at Econpapers || Download paper

2
212016Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Ampadu, Haggar H ; Sartori, Daniele ; Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

2
222016Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. (2016). Raschi, Emanuel ; de Ponti, Fabrizio ; Ageno, Walter ; Bianchin, Matteo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0464-3.

Full description at Econpapers || Download paper

2
232016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A ; Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

2
242014Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. (2014). Lindquist, Marie ; Bate, Andrew ; Tuccori, Marco ; Hartigan-Go, Kenneth ; Beckmann, Jurgen ; McEwen, John ; Moride, Yola ; Wong, Ian ; Hagemann, Ulrich ; Boyd, Ian ; Olsson, Sten ; Edwards, I. ; Pal, Shanthi ; Pan, Gerald Dal ; Soulaymani-Bencheikh, Rachida ; Vaca, Claudia ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:743-759.

Full description at Econpapers || Download paper

2
252016Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Brosch, Sabine ; Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

2
262017Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice. (2017). Stocks, Jill S ; Ashcroft, Darren M ; Burns, Alistair ; Avery, Anthony J ; Webb, Roger T ; Kontopantelis, Evangelos. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0538-x.

Full description at Econpapers || Download paper

2
2720192
282018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Duong, Mai ; Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

2
292016Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports. (2016). Klein, Kevin ; Puijenbroek, Eugene P ; Broekmans, Andre W ; Stolk, Pieter ; Bruin, Marie L ; Vermeer, Niels S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0383-8.

Full description at Econpapers || Download paper

2
302017Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases. (2017). Ferrajolo, Carmen ; Capuano, Annalisa ; Rossi, Francesco ; Stricker, Bruno H ; Mazzaglia, Giampiero ; Giaquinto, Carlo ; Picelli, Gino ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0493-y.

Full description at Econpapers || Download paper

2
312018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Watson, Sarah ; Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

2
322016National ADR Monitoring System in China. (2016). Wu, Guizhi ; Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5.

Full description at Econpapers || Download paper

2
332016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Benattia, Isma ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

2
342018Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Saucier, Roxanne ; Dasgupta, Nabarun ; Wolfe, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0653-3.

Full description at Econpapers || Download paper

2
352016The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. (2016). Garbe, Edeltraut ; Pariente, Antoine ; Koci, Ariola ; Salvo, Francesco ; Moretti, Ugo ; Hazell, Lorna ; Perina, Luisella ; Ponti, Fabrizio ; Antoniazzi, Stefania ; Sturkenboom, Miriam ; Raschi, Emanuel ; Suling, Marc ; Poluzzi, Elisabetta . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0353-1.

Full description at Econpapers || Download Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. (2017). Deshayes, Samuel ; Verdon, Renaud ; Coquerel, Antoine. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0578-2.

Full description at Econpapers || Download paper

1
372018Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Suggs, Courtney M ; zhao, liang ; Swain, Richard S ; Mosholder, Andrew D ; Levin, Robert L. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0726-3.

Full description at Econpapers || Download paper

1
382019Safety and Tolerability of Adoptive Cell Therapy in Cancer. (2019). Coukos, George ; Trueb, Lionel ; Irving, Melita ; Arber, Caroline ; Zimmermann, Stefan ; Wolf, Benita. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0779-3.

Full description at Econpapers || Download paper

1
392016Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin. (2016). Seger, Diane L ; Lai, Kenneth ; Topaz, Maxim ; Rozenblum, Ronen ; Dhopeshwarkar, Neil ; Zhou, LI ; Goss, Foster ; Saadon, Roee . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0381-x.

Full description at Econpapers || Download paper

1
402017Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification. (2017). Onakpoya, Igho J ; Aronson, Jeffrey K ; Heneghan, Carl J. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0515-4.

Full description at Econpapers || Download paper

1
412018Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”. (2018). Chandler, Rebecca Ellen ; Lindquist, Marie ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:5:d:10.1007_s40264-018-0657-z.

Full description at Econpapers || Download paper

1
422016A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports. (2016). Dimbil, MO ; Kyle, Robert F ; Hoffman, Keith B ; Tatonetti, Nicholas P. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0409-x.

Full description at Econpapers || Download paper

1
432017Comment on: “Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts”. (2017). Wiwanitkit, Viroj . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0537-y.

Full description at Econpapers || Download paper

1
442019Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”. (2019). Jandhyala, Ravi. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00862-x.

Full description at Econpapers || Download paper

1
452016Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients. (2016). Mantel-Teeuwisse, Aukje K ; Lartey, Margaret ; Nartey, Edmund T ; Tetteh, Raymond A ; Alexander, ; Yankey, Barbara A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0460-7.

Full description at Econpapers || Download paper

1
462017Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. (2017). Alshehri, Ghadah H ; Ashcroft, Darren M ; Keers, Richard N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0557-7.

Full description at Econpapers || Download paper

1
472018What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. (2018). van Eekeren, Rike ; Harmark, Linda ; van Puijenbroek, Eugene ; Tanaka, Daisuke ; Schutte, Tim ; al Ramimmy, Hussain ; Parthasarathi, Gurumurthy ; Magro, Lara ; Koster, Andries S ; Rolfes, Lean . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z.

Full description at Econpapers || Download Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer. (2019). Castanon, Eduardo ; Ponz-Sarvise, Mariano ; Melero, Ignacio ; Baraibar, Iosune. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0774-8.

Full description at Econpapers || Download paper

1
492016Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial. (2016). Lefebvre, Craig R ; McCormack, Lauren ; Rausch, Paula ; Taylor, Olivia ; Bann, Carla . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0358-9.

Full description at Econpapers || Download paper

1
502019Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study. (2019). Trifiro, Gianluca ; Sturkenboom, Miriam ; Lei, Johan ; Ridder, Maria ; Wilde, Marcel ; Leal, Ingrid ; Sultana, Janet. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-018-00785-z.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

4
22018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Trifiro, Gianluca ; Bate, Andrew ; Sultana, Janet. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
32016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

3
42017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Iyer, Geetha ; Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
52017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Caster, Ola ; Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

3
62016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Antoni, ; Tregunno, Phil ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Saucier, Roxanne ; Dasgupta, Nabarun ; Wolfe, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0685-8.

Full description at Econpapers || Download paper

2
92017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). Vries, Sieta T ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

2
102018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Watson, Sarah ; Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

2
1120192
122018Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs. (2018). Cheng, Ning ; Hansen, Richard A ; Page, David C ; Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:4:d:10.1007_s40264-017-0624-0.

Full description at Econpapers || Download paper

2
1320192
142016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Wahab, Izyan A ; Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

2
152016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Benattia, Isma ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

2
162018Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Saucier, Roxanne ; Dasgupta, Nabarun ; Wolfe, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0653-3.

Full description at Econpapers || Download paper

2
172017Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases. (2017). Ferrajolo, Carmen ; Capuano, Annalisa ; Rossi, Francesco ; Stricker, Bruno H ; Mazzaglia, Giampiero ; Giaquinto, Carlo ; Picelli, Gino ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0493-y.

Full description at Econpapers || Download paper

2
182018Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths. (2018). Ferner, Robin E ; Cox, Anthony R ; Easton, Craig. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0588-0.

Full description at Econpapers || Download paper

2
192018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Duong, Mai ; Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

2
202016Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. (2016). Raschi, Emanuel ; de Ponti, Fabrizio ; Ageno, Walter ; Bianchin, Matteo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0464-3.

Full description at Econpapers || Download paper

2
212017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark ; Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 14
YearTitle
2019Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study. (2019). Denig, Petra ; Tregunno, Phil ; Ragunathan, Gowthamei ; Radecka, Anna ; Ptaszynska-Neophytou, Alicia ; Revelle, Patrick ; Harrison, Judy ; de Vries, Sieta T ; PEter, . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00800-x.

Full description at Econpapers || Download paper

2019Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem. (2019). Campbell, Eric G ; Sinha, Michael S ; Kesselheim, Aaron S ; Dal, Gerald J ; Avorn, Jerry ; Zhou, Esther H ; Lappin, Brian M ; Rausch, Paula ; Schneeweiss, Sebastian. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00849-8.

Full description at Econpapers || Download paper

2019The Role of European Patient Organizations in Pharmacovigilance. (2019). Matos, Cristiano ; Hunsel, Florence ; Weits, Gerda. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

2019Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews. (2019). Gatti, Milo ; Bianchin, Matteo ; Raschi, Emanuel ; de Ponti, Fabrizio ; Squizzato, Alessandro. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00866-7.

Full description at Econpapers || Download paper

2019Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study. (2019). Gardarsdottir, Helga ; Souverein, Patrick C ; Giezen, Thijs J ; Minnema, Lotte A. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-018-00789-9.

Full description at Econpapers || Download paper

2019Drug-Induced Liver Injury: Highlights of the Recent Literature. (2019). Real, Mark ; Lewis, James H ; Rosenberg, Jessica ; Higley, Cory ; Barnhill, Michele S. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0743-2.

Full description at Econpapers || Download paper

2019Preventing Future Deaths from Medicines: Responses to Coroners’ Concerns in England and Wales. (2019). Ferner, Robin E ; Cox, Anthony R ; Babatunde, Zainab ; Ahmad, Tohfa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0738-z.

Full description at Econpapers || Download paper

2019The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa ; Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-01
2019Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study. (2019). Schink, Tania ; Kollhorst, Bianca ; Princk, Christina ; Schafer, Wiebke. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00837-y.

Full description at Econpapers || Download paper

2019From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data. (2019). Koutkias, Vassilis. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00793-z.

Full description at Econpapers || Download paper

2019Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives. (2019). Kant, Agnes ; Capuano, Annalisa ; Leone, Roberto ; Caduff, Pia ; Puijenbroek, Eugene ; Addis, Antonio ; Venegoni, Mauro ; Moretti, Ugo ; Tuccori, Marco ; Sultana, Janet ; Trifiro, Gianluca ; Sartori, Daniele ; Raine, June ; Lindquist, Marie ; Laporte, Joan-Ramon. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0768-6.

Full description at Econpapers || Download Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review. (2019). Sutherland, Adam ; Keers, Richard N ; Alghamdi, Anwar A ; Ashcroft, Darren M. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00856-9.

Full description at Econpapers || Download paper

2019Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System. (2019). Moore, Nicholas ; Gulmez, Sinem Ezgi ; Droz-Perroteau, Cecile ; Thurin, Nicolas ; Duong, Mai ; Barbet, Vanessa ; Lassalle, Regis ; Grolleau, Adeline ; Duret, Stephanie. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0752-1.

Full description at Econpapers || Download paper

2019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). , Antoni ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia ; Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Antoni, ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download

Recent citations
Recent citations received in 2019

YearCiting document
2019Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulator. (2019). Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia ; PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel ; Castillon, Mireia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00863-w.

Full description at Econpapers || Download Safety of Novel Targeted Therapies in Oncology. (2019). Curigliano, Giuseppe ; Shah, Rashmi R. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0770-z.

Full description at Econpapers || Download paper

2019From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data. (2019). Koutkias, Vassilis. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00793-z.

Full description at Econpapers || Download paper

2019Frailty and Drug Safety at Older Ages. (2019). Gulliford, Martin . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00796-4.

Full description at Econpapers || Download paper

Recent citations received in 2018

YearCiting document
2018Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Silverman, Bernard ; Akerman, Sarah ; Sullivan, Maria ; Fratantonio, James ; Silveira, Alexandra ; Marcopul, Kimberley ; Jain, Priya ; Bloomgren, Gary. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0691-x.

Full description at Econpapers || Download paper

2018Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Dasgupta, Nabarun ; Wolfe, Daniel ; Saucier, Roxanne. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0692-9.

Full description at Econpapers || Download paper

2018Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. (2018). Binswanger, Ingrid A ; Glanz, Jason M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0705-8.

Full description at Econpapers || Download paper

2018Reply to Ward and Colleagues’ Comment on “Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”. (2018). Jerome, Rebecca N ; Denny, Joshua C ; Lancaster, William J ; Ekstrom, Leeland ; Bernard, Gordon ; Bastarache, Lisa A ; Shirey-Rice, Jana K ; Roden, Dan M ; Pulley, Jill M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0701-z.

Full description at Econpapers || Download paper

2018Ibuprofen and Paracetamol: Acceptably Safe for All?. (2018). Pigazzani, Filippo ; MacDonald, Thomas M ; MacKenzie, Isla. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0717-4.

Full description at Econpapers || Download paper

2018Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action. (2018). Raine, June ; Radecka, Anna ; Ivanovic, Jelena ; Pallos, Julia ; Montero, Dolores ; Straus, Sabine ; Lesicar, Marina ; Giusti, Marina Dimov ; Sarinic, Viola Macolic ; de Ferraz, Margarida Viana ; Foy, Mick ; Loughlin, Louise. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0708-5.

Full description at Econpapers || Download paper

2018Authors’ Response to Braillon’s Comment on: “Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring”. (2018). Simoons, Mirjam ; Ruhe, Henricus ; Bakker, Roberto ; Roon, Eric ; Mulder, Hans ; Seldenrijk, Adrie. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0716-5.

Full description at Econpapers || Download paper

2018Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Suggs, Courtney M ; zhao, liang ; Swain, Richard S ; Mosholder, Andrew D ; Levin, Robert L. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0726-3.

Full description at Econpapers || Download paper

2018Authors Reply to Courtney Suggs and Colleagues’ Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Hansen, Richard A ; Page, David C ; Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD ; Cheng, Ning. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0728-1.

Full description at Econpapers || Download pape

2018Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”. (2018). Cohen, Carine ; Khromava, Alena ; Houdeau, Annick. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0733-4.

Full description at Econpapers || Download paper

2018Authors’ Reply to Katsuhiro Toda’s Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case-Control Analysis”. (2018). Imfeld, Patrick ; Meier, Christoph R ; Jick, Susan S ; Bodmer, Michael. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0741-4.

Full description at Econpapers || Download paper

2018Comment on “Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project”. (2018). Bousquet, Cedric ; Louet, Agnes Lillo-Le ; Bellet, Florelle ; Audeh, Bissan. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0747-y.

Full description at Econpapers || Download paper

2018Authors’ reply: Safety of Human Papillomavirus Vaccines. (2018). MacArtney, Kristine ; Brotherton, Julia ; Pillsbury, Alexis ; Patel, Cyra ; Phillips, Anastasia. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:5:d:10.1007_s40264-018-0655-1.

Full description at Econpapers || Download paper

2018Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population”. (2018). Kawada, Tomoyuki . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0670-2.

Full description at Econpapers || Download paper

2018Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a . (2018). Peckham, Alyssa M ; Sclar, David A ; Fairman, Kathleen A. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0671-1.

Full description at Econpapers || Download paper

2018Active Safety Surveillance in Africa: Pragmatism and Agility. (2018). Alexander, . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0677-8.

Full description at Econpapers || Download paper

2018Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis. (2018). Maura, Geric ; Pariente, Antoine ; Neumann, Anke ; Weill, Alain ; Coste, Joel ; Billionnet, Cecile. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0668-9.

Full description at Econpapers || Download paper

Recent citations received in 2017

YearCiting document
2017Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook. (2017). Huesch, Marco D. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0577-3.

Full description at Econpapers || Download paper

2017Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?. (2017). Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0593-3.

Full description at Econpapers || Download paper

2017Is Ribavirin Teratogenic in Humans? No Evidence So Far. (2017). Soriano, Vicente ; Barreiro, Pablo. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0597-z.

Full description at Econpapers || Download paper

2017Authors’ Reply to Jouanjus and Colleagues’ Comment on “Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter”. (2017). Sarker, Abeed ; Malone, Dan ; Gonzalez, Graciela . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:2:d:10.1007_s40264-016-0498-6.

Full description at Econpapers || Download paper

2017Authors’ Reply to Alain Braillon’s Comment on “Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing pr. (2017). Auffret, Marine ; Rolland, Benjamin ; Gautier, Sophie ; Bordet, Regis ; Cottencin, Olivier ; Deheul, Sylvie ; Duhamel, Alain ; Labreuche, Julien . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-017-0513-6.

Full description at Econpapers || Download Medicines Save, Medicines Kill. (2017). Lexchin, Joel . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:6:d:10.1007_s40264-017-0521-6.

Full description at Econpapers || Download paper

2017The Power of the Case Narrative - Can it be Brought to Bear on Duplicate Detection?. (2017). Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0548-8.

Full description at Econpapers || Download paper

2017Good Intentions, But What About Unintended Consequences?. (2017). Kales, Helen C ; Maust, Donovan T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0554-x.

Full description at Econpapers || Download paper

Recent citations received in 2016

YearCiting document
2016Authors’ Reply to Alain Braillon’s Comment on “Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence”. (2016). Chambers, Sophia E ; Baldwin, David S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0448-3.

Full description at Econpapers || Download paper

2016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

2016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Grampp, Gustavo ; Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

2016On Designs for Vaccine Surveillance. (2016). Platt, Robert W. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0457-2.

Full description at Econpapers || Download paper

2016Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. (2016). Raschi, Emanuel ; de Ponti, Fabrizio ; Ageno, Walter ; Bianchin, Matteo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0464-3.

Full description at Econpapers || Download paper

2016Authors’ Reply to Alain Braillon’s Comment on “The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project”. (2016). Raschi, Emanuel ; Ponti, Fabrizio ; Poluzzi, Elisabetta ; Salvo, Francesco ; Moretti, Ugo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-016-0404-2.

Full description at Econpapers || Download paper

2016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Antoni, ; Tregunno, Phil ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download